Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | AMGN | GILD | BIIB | CELG |
| Company | Crispr Therapeutics Ag | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 55.40 | 269.84 | 66.93 | 196.19 | 108.01 |
| High | 56.93 | 273.14 | 67.57 | 196.77 | 108.59 |
| Low | 54.37 | 269.84 | 66.74 | 193.23 | 107.27 |
| Last | 55.66 | 271.91 | 66.95 | 194.11 | 108.24 |
| Change | +0.61 | +2.98 | +0.19 | -0.27 | +0.11 |
| % Change | +1.11% | +1.11% | +0.28% | -0.14% | +0.10% |
| Volume | 1,044,300 | 2,165,700 | 5,622,300 | 1,119,500 | 191,230,496 |
| 20-Day Average Volume | 1,299,765 | 2,239,560 | 6,350,505 | 1,143,425 | 16,188,930 |
| Previous Close | 55.05 | 268.93 | 66.76 | 194.38 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 62.99 | 272.35 | 69.61 | 203.84 | 108.17 |
| 20-Day Raw Stochastic | 7.36% | 40.27% | 13.17% | 16.20% | 63.25% |
| 20-Day Relative Strength | 32.02% | 47.06% | 32.36% | 32.22% | 64.69% |
| Weighted Alpha | -11.07 | +10.54 | -20.99 | -38.16 | +46.30 |
| Today's Opinion | 24% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 24% Sell | 56% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 80% Buy | 8% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.21% since 04/15/24 | +2.41% since 04/15/24 | -1.18% since 04/15/24 | -1.37% since 04/15/24 | -1.97% since 11/13/19 |
| Low | 54.28 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 107.27 on 11/20/19 |
| High | 58.74 on 04/16/24 | 273.14 on 04/22/24 | 67.89 on 04/16/24 | 197.73 on 04/16/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -22.27% since 03/22/24 | -1.54% since 03/22/24 | -7.80% since 03/22/24 | -11.00% since 03/22/24 | +5.14% since 10/18/19 |
| Low | 54.28 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 73.09 on 03/26/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 218.26 on 03/25/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -14.71% since 01/22/24 | -12.33% since 01/22/24 | -14.64% since 01/22/24 | -21.82% since 01/22/24 | +13.63% since 08/20/19 |
| Low | 54.28 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 91.10 on 02/22/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +44.12% since 10/20/23 | -2.47% since 10/20/23 | -13.95% since 10/20/23 | -24.60% since 10/20/23 | +14.14% since 05/20/19 |
| Low | 37.55 on 10/23/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 91.10 on 02/22/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,724,588 | 145,845,984 | 83,357,904 | 28,216,022 | 77,035,920 |
| Shares Outstanding, K | 84,883 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 371,210,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -153,610,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 201,210,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | 89,350,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 1.76 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.10 on 02/21/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 9.93 | 13.20 | 10.99 |